Final rule 2025-18239
Regulation Identification Number 0910-AJ05 Medical Devices; Laboratory Developed Tests; Implementation of Vacatur
On May 6, 2024, the Food and Drug Administration (FDA, the Agency, or we) issued a final rule amending the definition of "in vitro diagnostic products" in FDA's regulations. On March 31, 2025, a federal district court vacated that rule. This final rule reverts to the text of the regulation as it existed prior to the effective date of the May 2024 final rule.
Source-supplied record
Document details
- Document number
- 2025-18239
- Published
- Sep 19, 2025
- Effective
- Sep 19, 2025
- Comments close
- Not supplied
- Federal Register citation
- 90 FR 45134
Docket identifiers
- Docket No. FDA-2025-N-1730
CFR references
- Title 21, part 809